Company: PSTV
Filing Date: 2025-04-01
Form Type: PRER14A
Source: 0001140361-25-011649
Chunk: 24

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-01
Form: PRER14A
Chunk 24
---
 |

| • | to give full effect to the adjustment in the exercise price and number of Series A Warrant Shares following a Dilutive Issuance (as defined therein) pursuant to Section 3.2 of the Series A Warrants; |

| • | to give full effect to the zero exercise price provision pursuant to Section 2.3 of the Series B Warrants; |

| • | to consent to any adjustment of the exercise price and number of (i) Series A Warrant Shares pursuant to Section 3.3 of the Series A Warrants, and (ii) Series B Warrant Shares pursuant to Section 3.2 of the Series B Warrants; |

13

TABLE OF CONTENTS

| • | to consent to any adjustment of the exercise price or number of (i) Series A Warrant Shares in the event of a Share Combination Event (as defined therein) pursuant to Section 3.9 of the Series A Warrants, and (ii) Series B Warrant Shares in the event of a Share Combination Event pursuant to Section 3.8 of the Series B Warrants; and |

| • | to consent to the voluntary adjustment, from time to time, of the exercise price of any and all currently outstanding (i) Series A Warrants pursuant to Section 3.10 of the Series A Warrants, and (ii) Series B Warrants pursuant to Section 3.9 of the Series B Warrants. |

Pursuant to the terms of the Warrants, we are also seeking in Proposal 3 an increase in the number of authorized shares of Common Stock under the Company’s Certificate of Incorporation. Background On March 4, 2025, the Company consummated the Private Placement pursuant to the Purchase Agreement. The Purchase Agreement provided for the sale and issuance by the Company of an aggregate of 28,042,140 shares of the Company’s Common Stock, or, at the election of each Purchaser, Prefunded Warrants, with each share of Common Stock or Prefunded Warrant accompanied by (i) one Series A Warrants to purchase one Series A Warrant Share, and (ii) one Series B Warrants to purchase one Series B Warrant Share. The combined purchase price of $0.66 for each share of Common Stock, or $0.659 for each Prefunded Warrant in the Private Placement, together with one accompanying Series A Warrant and one accompanying Series B Warrant, represented the applicable “Minimum Price” in accordance with